Key result
Gut microbiome and metabolic shifts identify post-stroke depression severity with an AUC of ~0.81.
Why the study?
Post-stroke depression (PSD) significantly impacts patient prognosis, but the associations among gut microbial ecology, metabolic profiles, and inflammatory responses across PSD severities are not well characterized.
Does post-stroke depression severity correlate with specific gut microbial, metabolic, and systemic inflammatory signatures in post-stroke patients?
Cross-Sectional (n=91)
Does post-stroke depression severity correlate with specific gut microbial, metabolic, and systemic inflammatory signatures in post-stroke patients?
Answers are grounded in this paper and cite their sources.
Multi-omics profiling reveals severity-specific gut microbiota dysbiosis and tryptophan/lipid metabolic remodeling in post-stroke depression, offering candidate biomarker panels for disease stratification.
Post-stroke depression (PSD) is a common complication that significantly impacts patient prognosis. This study aimed to systematically characterize the associations among gut microbial ecology, metabolic profiles, and inflammatory responses across different severities of PSD. We conducted metagenomic sequencing, non-targeted metabolomics, and serum cytokine analysis (IL-1β, IL-6, IL-10, IL-18, TNF-α, IFN-γ, and CRP) in 91 patients with varying degrees of PSD and non-PSD controls. Bioinformatics analyzes were employed to construct multi-omics association networks and machine learning models. Results indicated that PSD patients exhibited significantly increased gut microbiota alpha-diversity, suggesting dysbiosis. Mild depression was characterized by compensatory neural signaling activation, whereas the moderate depression group exhibited abnormalities in tryptophan/indole metabolism, oxidative stress-related metabolic imbalances, and functional decompensation. Further analyzes suggested that Alistipes, Blautia_A, Evtepia gabavorous, and Lachnospira were associated with inflammatory features, GABA-related metabolic alterations, aromatic amino acid/indole metabolism, and lipid-amino acid metabolism, respectively. Under a more rigorous 10-fold cross-validation framework, the performance of different multi-omics combination models showed heterogeneity; however, some combinations still demonstrated superior discriminatory ability compared to single-omics approaches. This study provides multi-omics clues suggesting associations between different PSD severity levels and features such as increased Alistipes abundance, reduced antioxidant capacity, and altered tryptophan metabolism. It provides candidate biomarker combinations that may be useful for PSD stratification and suggests that the gut microbiome may represent a potential target for future PSD intervention. In summary, PSD may be associated with dynamic alterations along the “gut–brain-inflammation-metabolism” axis. These findings provide integrated evidence for microbial, metabolic, and inflammatory abnormalities across different PSD severity levels, but still require validation in larger samples, longitudinal cohorts, and mechanistic studies.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a cross-sectional in Post-stroke depression (PSD) (n=91). Post-stroke depression severity (mild and moderate PSD) vs. Non-depressed post-stroke patients (NPSD) was evaluated on Gut microbiota diversity, fecal and serum metabolomic profiles, serum inflammatory markers, and multi-omics classification of PSD states (AUC 0.806, 95% CI 0.714-0.880, p=0.004975). Post-stroke depression severity was associated with increased gut microbiota alpha-diversity and distinct metabolic shifts, with a combined species-metabolite model achieving an AUC of 0.806.
Synapse has enriched 10 related papers. Consider them for comparative context: